{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:58:02Z","timestamp":1793739482178,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Science and Technology Program in Gansu Province","award":["NO.21YF5FA016"],"award-info":[{"award-number":["NO.21YF5FA016"]}]},{"name":"The Natural Science Foundation of Gansu Province","award":["No.22JR5RA650"],"award-info":[{"award-number":["No.22JR5RA650"]}]},{"name":"Research Fund Project of Internal Medicine Department, Gansu Provincial Hospital","award":["22GSSYD-15"],"award-info":[{"award-number":["22GSSYD-15"]}]},{"name":"Scientific Research Foundation of Gansu Provincial People's Hospital","award":["23GSSYD-12"],"award-info":[{"award-number":["23GSSYD-12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06691-0","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T02:33:26Z","timestamp":1750214006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Precise prediction of bone metastases and metastatic burden using exosomal mirnas and radiomics: a multi-center study"],"prefix":"10.1186","volume":"23","author":[{"given":"Chao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Pan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Xuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"6691_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2024.05.029","volume":"371","author":"MA Hamed","year":"2024","unstructured":"Hamed MA, Wasinger V, Wang Q, Graham P, Malouf D, Bucci J, Li Y. Prostate cancer-derived extracellular vesicles metabolic biomarkers: emerging roles for diagnosis and prognosis. J Control Releas. 2024;371:126\u201345.","journal-title":"J Control Releas"},{"key":"6691_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","volume":"8","author":"J Sturge","year":"2011","unstructured":"Sturge J, Caley MP, Waxman J. Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol. 2011;8:357\u201368.","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 3","key":"6691_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.20471\/acc.2022.61.s3.12","volume":"61","author":"T Omr\u010den","year":"2022","unstructured":"Omr\u010den T. Systemic triple therapy in metastatic hormone sensitive prostate cancer (MHSPC). Acta Clin Croat. 2022;61(Suppl 3):81\u20135. https:\/\/doi.org\/10.20471\/acc.2022.61.s3.12.","journal-title":"Acta Clin Croat"},{"issue":"11","key":"6691_CR4","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1200\/JCO.2017.75.3657","volume":"36","author":"CE Kyriakopoulos","year":"2018","unstructured":"Kyriakopoulos CE, Chen YH, Carducci MA, Liu G, Jarrard DF, Hahn NM, Shevrin DH, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack ER, Vogelzang NJ, Picus J, Cooney MM, Garcia JA, DiPaola RS, Sweeney CJ. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial. J Clin Oncol. 2018;36(11):1080\u20137. https:\/\/doi.org\/10.1200\/JCO.2017.75.3657.","journal-title":"J Clin Oncol"},{"key":"6691_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.21037\/tau-21-23","volume":"10","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang L, Zhou Y, Wang C, Ma Y, Zhao Y, Tian J, Huang H, Wang H, Wang Y, et al. Application of metastatic biopsy based on \u201cWhen, Who, Why, Where, How (4W1H)\u201d principle in diagnosis and treatment of metastatic castration-resistance prostate cancer. Transl Androl Urol. 2021;10:1723\u201333.","journal-title":"Transl Androl Urol"},{"key":"6691_CR6","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.3390\/ijms22189971","volume":"22","author":"M Ferro","year":"2021","unstructured":"Ferro M, de Cobelli O, Vartolomei MD, Lucarelli G, Crocetto F, Barone B, Sciarra A, Del Giudice F, Muto M, Maggi M, et al. Prostate cancer radiogenomics-from imaging to molecular characterization. Int J Mol Sci. 2021;22:9971.","journal-title":"Int J Mol Sci"},{"key":"6691_CR7","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.2147\/CMAR.S170380","volume":"11","author":"YT Lu","year":"2019","unstructured":"Lu YT, Delijani K, Mecum A, Goldkorn A. Current status of liquid biopsies for the detection and management of prostate cancer. Cancer Manag Res. 2019;11:5271\u201391.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"6691_CR8","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1172\/JCI81129","volume":"126","author":"R Xu","year":"2016","unstructured":"Xu R, Greening DW, Zhu HJ, Takahashi N, Simpson RJ. Vesicle isolation and characterization: toward clinical application. J Clin Invest. 2016;126(4):1152\u201362.","journal-title":"J Clin Invest"},{"issue":"9","key":"6691_CR9","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.7150\/jca.71706","volume":"13","author":"Y Wei","year":"2022","unstructured":"Wei Y, Chen Z, Zhang R, Wu B, Lin L, Zhu Q, Ye L, Li T, Li F. Blood circulating exosomes carrying microRNA-423-5p regulates cell progression in prostate cancer via targeting FRMD3. J Cancer. 2022;13(9):2970\u201381.","journal-title":"J Cancer"},{"issue":"8","key":"6691_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.3042","volume":"36","author":"G Ashok","year":"2023","unstructured":"Ashok G, Das R, Anbarasu A, Ramaiah S. Comprehensive analysis on the diagnostic role of circulatory exosome-based miR-92a-3p for osteoblastic metastases in prostate adenocarcinoma. J Mol Recognit. 2023;36(8): e3042.","journal-title":"J Mol Recognit"},{"issue":"10","key":"6691_CR11","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1007\/s00330-023-09642-9","volume":"33","author":"F Marturano","year":"2023","unstructured":"Marturano F, Guglielmo P, Bettinelli A, Zattoni F, Novara G, Zorz A, Sepulcri M, Gregianin M, Paiusco M, Evangelista L. Role of radiomic analysis of 18 F fluoromethylcholine PET\/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging. Eur Radiol. 2023;33(10):7199\u2013208.","journal-title":"Eur Radiol"},{"key":"6691_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/cancers15184437","volume":"15","author":"SR Duenweg","year":"2023","unstructured":"Duenweg SR, Bobholz SA, Barrett MJ, Lowman AK, Winiarz A, Nath B, Stebbins M, Bukowy J, Iczkowski KA, Jacobsohn KM, Vincent-Sheldon S, LaViolette PS. T2-weighted MRI radiomic features predict prostate cancer presence and eventual biochemical recurrence. Cancers (Basel). 2023;15:18.","journal-title":"Cancers (Basel)"},{"key":"6691_CR13","doi-asserted-by":"publisher","first-page":"1060687","DOI":"10.3389\/fonc.2023.1060687","volume":"13","author":"JCF Ching","year":"2023","unstructured":"Ching JCF, Lam S, Lam CCH, Lui AOY, Kwong JCK, Lo AYH, Chan JWH, Cai J, Leung WS, Lee SWY. Integrating CT-based radiomic model with clinical features improves long-term prognostication in high-risk prostate cancer. Front Oncol. 2023;13:1060687.","journal-title":"Front Oncol"},{"issue":"1","key":"6691_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12672-023-00752-w","volume":"14","author":"C Zhou","year":"2023","unstructured":"Zhou C, Zhang YF, Guo S, Wang D, Lv HX, Qiao XN, Wang R, Chang DH, Zhao LM, Zhou FH. Multiparametric MRI radiomics in prostate cancer for predicting Ki-67 expression and Gleason score: a multicenter retrospective study. Discov Oncol. 2023;14(1):133.","journal-title":"Discov Oncol"},{"key":"6691_CR15","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:6478.","journal-title":"Science"},{"key":"6691_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers15225449","volume":"15","author":"L Hofmann","year":"2023","unstructured":"Hofmann L, Harasymczuk M, Huber D, et al. Arginase-1 in plasma-derived exosomes as marker of metastasis in patients with head and neck squamous cell carcinoma. Cancers (Basel). 2023;15:22.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"6691_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21059","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zheng K, Gao Y, et al. Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer. Heliyon. 2023;9(10): e21059.","journal-title":"Heliyon"},{"issue":"22","key":"6691_CR18","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.3748\/wjg.v29.i22.3482","volume":"29","author":"X Li","year":"2023","unstructured":"Li X, Lin YL, Shao JK, et al. Plasma exosomal hsa_circ_0079439 as a novel biomarker for early detection of gastric cancer. World J Gastroenterol. 2023;29(22):3482\u201396.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"6691_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.euf.2016.09.007","volume":"4","author":"W Zhang","year":"2018","unstructured":"Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G. MicroRNAs in serum exosomes as potential biomarkers in clear-cell renal cell carcinoma. Eur Urol Focus. 2018;4(3):412\u20139. https:\/\/doi.org\/10.1016\/j.euf.2016.09.007.","journal-title":"Eur Urol Focus"},{"issue":"6","key":"6691_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101\u20138. https:\/\/doi.org\/10.1038\/nprot.2008.73.","journal-title":"Nat Protoc"},{"issue":"3","key":"6691_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"11","key":"6691_CR22","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1109\/LSP.2014.2337313","volume":"21","author":"X Sun","year":"2014","unstructured":"Sun X, Xu W. Fast implementation of delong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process Lett. 2014;21(11):1389\u201393. https:\/\/doi.org\/10.1109\/LSP.2014.2337313.","journal-title":"IEEE Signal Process Lett"},{"issue":"2","key":"6691_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/CIRCRESAHA.113.300636","volume":"114","author":"DM Yellon","year":"2014","unstructured":"Yellon DM, Davidson SM. Exosomes: nanoparticles involved in cardioprotection? Circ Res. 2014;114(2):325\u201332. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300636.","journal-title":"Circ Res"},{"key":"6691_CR24","doi-asserted-by":"publisher","first-page":"1127637","DOI":"10.3389\/fonc.2023.1127637","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Jiang P, Wang C. The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review. Front Oncol. 2023;13:1127637.","journal-title":"Front Oncol"},{"key":"6691_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1993.03500010067033","volume":"269","author":"JE Oesterling","year":"1993","unstructured":"Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA. 1993;269:57\u201360.","journal-title":"JAMA"},{"issue":"5","key":"6691_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1442-2042.2008.02029.x","volume":"15","author":"C Ozu","year":"2008","unstructured":"Ozu C, Nakashima J, Horiguchi Y, Oya M, Ohigashi T, Murai M. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Int J Urol. 2008;15(5):419\u201322.","journal-title":"Int J Urol"},{"issue":"1","key":"6691_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12863-021-00997-w","volume":"22","author":"I Rooda","year":"2021","unstructured":"Rooda I, Kaselt B, Liivrand M, Smolander OP, Salumets A, Velthut-Meikas A. Hsa-mir-548 family expression in human reproductive tissues. BMC Genom Data. 2021;22(1):40.","journal-title":"BMC Genom Data"},{"issue":"7","key":"6691_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/mc.23545","volume":"62","author":"ER Hahm","year":"2023","unstructured":"Hahm ER, Kim SH, Singh SV. Withaferin A inhibits breast cancer-induced osteoclast differentiation. Mol Carcinog. 2023;62(7):1051\u201361.","journal-title":"Mol Carcinog"},{"key":"6691_CR29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1476-4598-9-258","volume":"9","author":"SK Baniwal","year":"2010","unstructured":"Baniwal SK, Khalid O, Gabet Y, et al. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis. Mol Cancer. 2010;9:258.","journal-title":"Mol Cancer"},{"issue":"1","key":"6691_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10585-018-9951-5","volume":"36","author":"WG Chen","year":"2019","unstructured":"Chen WG, Sun J, Shen WW, et al. Sema4D expression and secretion are increased by HIF-1\u03b1 and inhibit osteogenesis in bone metastases of lung cancer. Clin Exp Metastasis. 2019;36(1):39\u201356. https:\/\/doi.org\/10.1007\/s10585-018-9951-5.","journal-title":"Clin Exp Metastasis"},{"issue":"3","key":"6691_CR31","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1159\/000494533","volume":"50","author":"T Liao","year":"2018","unstructured":"Liao T, Chen W, Sun J, et al. CXCR4 accelerates osteoclastogenesis induced by non-small cell lung carcinoma cells through self-potentiation and VCAM1 secretion. Cell Physiol Biochem. 2018;50(3):1084\u201399.","journal-title":"Cell Physiol Biochem"},{"key":"6691_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.mri.2019.03.007","volume":"60","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yu B, Zhong F, Guo Q, Li K, Hou Y, Lin N. MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer. Magn Reson Imag. 2019;60:76\u201384.","journal-title":"Magn Reson Imag"},{"issue":"3","key":"6691_CR33","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00330-021-08245-6","volume":"32","author":"R Hinzpeter","year":"2022","unstructured":"Hinzpeter R, Baumann L, Guggenberger R, Huellner M, Alkadhi H, Baessler B. Radiomics for detecting prostate cancer bone metastases invisible in CT: a proof-of-concept study. Eur Radiol. 2022;32(3):1823\u201332. https:\/\/doi.org\/10.1007\/s00330-021-08245-6.","journal-title":"Eur Radiol"},{"key":"6691_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213596","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang H, Woon DTS, Perera M, Lawrentschuk N. Predicting biochemical recurrence of prostate cancer post-prostatectomy using artificial intelligence: a systematic review. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16213596.","journal-title":"Cancers (Basel)"},{"key":"6691_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract15010004","author":"E Bekou","year":"2024","unstructured":"Bekou E, Mulita A, Seimenis I, Kotini A, Courcoutsakis N, Koukourakis MI, Mulita F, Karavasilis E. Magnetic resonance imaging techniques for post-treatment evaluation after external beam radiation therapy of prostate cancer: narrative review. Clin Pract. 2024. https:\/\/doi.org\/10.3390\/clinpract15010004.","journal-title":"Clin Pract"},{"key":"6691_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0228","author":"R Raychaudhuri","year":"2025","unstructured":"Raychaudhuri R, Lin DW, Montgomery RB. Prostate cancer: a review. JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.0228.","journal-title":"JAMA"},{"key":"6691_CR37","doi-asserted-by":"publisher","first-page":"1298516","DOI":"10.3389\/fonc.2024.1298516","volume":"14","author":"S Xinyang","year":"2024","unstructured":"Xinyang S, Tianci S, Xiangyu H, Shuang Z, Yangyang W, Mengying D, Tonghui X, Jingran Z, Feng Y. A semi-automatic deep learning model based on biparametric MRI scanning strategy to predict bone metastases in newly diagnosed prostate cancer patients. Front Oncol. 2024;14:1298516. https:\/\/doi.org\/10.3389\/fonc.2024.1298516.","journal-title":"Front Oncol"},{"issue":"2","key":"6691_CR38","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232635","volume":"312","author":"JC Cai","year":"2024","unstructured":"Cai JC, et al. Fully automated deep learning model to detect clinically significant prostate cancer at MRI. Radiology. 2024;312(2): e232635. https:\/\/doi.org\/10.1148\/radiol.232635.","journal-title":"Radiology"},{"issue":"3","key":"6691_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00259-022-06036-9","volume":"50","author":"L Zhao","year":"2023","unstructured":"Zhao L, et al. Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study. Eur J Nucl Med Mol Imag. 2023;50(3):727\u201341. https:\/\/doi.org\/10.1007\/s00259-022-06036-9.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"6691_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2021.102288","volume":"75","author":"I Bhattacharya","year":"2022","unstructured":"Bhattacharya I, et al. Selective identification and localization of indolent and aggressive prostate cancers via CorrSigNIA: an MRI-pathology correlation and deep learning framework. Med Imag Anal. 2022;75: 102288. https:\/\/doi.org\/10.1016\/j.media.2021.102288.","journal-title":"Med Imag Anal"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06691-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06691-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T02:33:27Z","timestamp":1750214007000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06691-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6691"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06691-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Gansu Provincial People's Hospital (2021-260) and the requirement for informed consent was waived. The ethical approval was in Supplementary material.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"677"}}